CVE-2026-21980 MEDIUM

CVE-2026-21980

Vendor Oracle Corporation
Product Oracle Life Sciences Central Coding
Published January 20, 2026
Last update January 21, 2026

CVSS base score

6.5/10
Attack vector Network
Attack complexity Low
Privileges required None
User interaction None
Confidentiality Low
Integrity Low

CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

What the vulnerability does

01Description

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Key dates

02Disclosure timeline

January 20, 2026 CVE published
January 21, 2026 Record updated